Latest filing published 03 Sept 2024 for CYTOKINETICS INC.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Brett A. Pletcher: trading record in brief
Brett A. Pletcher (senior executive) discloses dealings in 2 companies, chiefly Gilead Sciences, Inc. and Cytokinetics Inc. The record holds 75 filings, for trades running from 31 July 2018 to 30 August 2024.
The open-market record consists of 24 sales worth €8.4M, with no purchase. Outside the open market, there are 28 share grants and 22 option exercises.
On 3 September 2024 came the latest disclosure, a share grant in Cytokinetics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brett A. Pletcher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 33,140 shares0Common StockSEC:0001127602-24-023331:0
- 782 sharesCommon StockSEC:0001127602-22-017328:0
- 348 shares@ US$52.1305100.0% of flowCommon StockSEC:0001127602-22-011955:0
- 2,593 sharesCommon StockSEC:0001127602-22-009215:0
- 1,691 shares@ US$63.899.9% of flowCommon StockSEC:0001127602-22-004516:0
- 2,727 shares0Common StockSEC:0001127602-22-003846:0
- 14,061 shares@ US$68.535889.9% of flowCommon StockSEC:0001127602-22-003048:0
- 15,262 shares0Common StockSEC:0001127602-22-002462:0
- 32 shares@ US$55.080.2% of flowCommon StockSEC:0001127602-21-024266:0
9 of 9 declarations
